Literature DB >> 3604893

Influence of heart rate on metabolic and hemodynamic parameters in the Syrian hamster cardiomyopathy.

W Markiewicz, S Wu, R Sievers, W W Parmley, C B Higgins, T L James, G Jasmin, J Wikman-Coffelt.   

Abstract

The effect of varying heart rate in 155- to 170-day-old isolated, perfused cardiomyopathic Syrian hamster hearts was evaluated by 31P nuclear magnetic resonance spectroscopy. At a low paced heart rate of 170 bpm, cardiomyopathic hearts did not differ from normal hearts except for a lower developed left ventricular pressure. As pacing rate was increased progressively to 270/min, cardiomyopathic hearts showed prolongation of contraction, which led to a pronounced rise in diastolic pressure as the interstimulus interval shortened. This was accompanied by a marked decrease in energy-rich phosphorus compounds. By contrast, increasing heart rate in normal hearts did not change left ventricular pressure and caused only a mild reduction in energy-rich phosphorus compounds. Intracellular pH of cardiomyopathic animals paced at 270 bpm was significantly lower than in normal animals. Thus, indices reflecting mitochondrial function of 155- to 170-day-old cardiomyopathic hamsters appear adequate at low heart rate. Increasing the heart rate unmasks latent mitochondrial dysfunction.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3604893     DOI: 10.1016/0002-8703(87)90504-7

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  2 in total

1.  Distinct modulation of myocardial performance, energy metabolism, and [Ca2+]i transients by positive inotropic drugs in normal and severely failing hamster hearts.

Authors:  P T Buser; S Y Wu; W W Parmley; G Jasmin; J Wikman-Coffelt
Journal:  Cardiovasc Drugs Ther       Date:  1995-02       Impact factor: 3.727

2.  δ-Sarcoglycan-deficient muscular dystrophy: from discovery to therapeutic approaches.

Authors:  Alison M Blain; Volker W Straub
Journal:  Skelet Muscle       Date:  2011-03-17       Impact factor: 4.912

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.